Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to Aeroallergens
暂无分享,去创建一个
S. Johnston | M. Paulsen | M. Edwards | R. Walton | T. Hansel | J. Dhariwal | M. Trujillo-Torralbo | Ross P. Walton | D. Jackson | D. Cousins | Batika M. J. Rana | Ajerico del Rosario | A. Cameron | E. Bakhsoliani | M. Trujillo‐Torralbo
[1] R. Mogg,et al. The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement , 2016, Mucosal Immunology.
[2] C. Bai,et al. IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. , 2016, American journal of respiratory cell and molecular biology.
[3] Xin Feng,et al. Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease. , 2016, The Journal of allergy and clinical immunology.
[4] I. Pavord,et al. Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial. , 2016, The Lancet. Respiratory medicine.
[5] Ruchong Chen,et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. , 2016, The Journal of allergy and clinical immunology.
[6] Richard J Martin,et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. , 2015, The Journal of allergy and clinical immunology.
[7] I. Hall,et al. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. , 2015, Pulmonary pharmacology & therapeutics.
[8] N. Papadopoulos,et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.
[9] Andrew A. White,et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. , 2014, Clinical immunology.
[10] Andrew McKenzie,et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation , 2014, Science Translational Medicine.
[11] H. Kita,et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. , 2014, The Journal of allergy and clinical immunology.
[12] P. Klenerman,et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells☆ , 2014, The Journal of allergy and clinical immunology.
[13] M. Gold,et al. Group 2 Innate Lymphoid Cells Are Critical for the Initiation of Adaptive T Helper 2 Cell-Mediated Allergic Lung Inflammation , 2014, Immunity.
[14] F. Liew,et al. Type 2 Innate Lymphoid Cells Drive CD4+ Th2 Cell Responses , 2014, The Journal of Immunology.
[15] N. Krug,et al. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. , 2014, The Journal of allergy and clinical immunology.
[16] G. Ogg,et al. A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis , 2013, The Journal of experimental medicine.
[17] M. Citardi,et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. , 2013, American journal of respiratory and critical care medicine.
[18] M. Croft,et al. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. , 2013, The Journal of allergy and clinical immunology.
[19] Pingsheng Wu,et al. Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype. , 2013, American journal of respiratory and critical care medicine.
[20] M. Hepworth,et al. TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation , 2013, Science Translational Medicine.
[21] F. Horak,et al. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial , 2012, Allergy.
[22] Hergen Spits,et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. , 2012, Immunity.
[23] Marjolein J. W. de Bruijn,et al. Pulmonary innate lymphoid cells are major producers of IL‐5 and IL‐13 in murine models of allergic asthma , 2012, European journal of immunology.
[24] Dave Singh,et al. Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 , 2012, European Respiratory Journal.
[25] P. Bozza,et al. Eosinophils as a Novel Cell Source of Prostaglandin D2: Autocrine Role in Allergic Inflammation , 2011, The Journal of Immunology.
[26] Hergen Spits,et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 , 2011, Nature Immunology.
[27] David J. Erle,et al. Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.
[28] J. Kolls. Faculty Opinions recommendation of IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. , 2010 .
[29] A. McKenzie,et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.
[30] Tsutomu Takeuchi,et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.
[31] C. Fielding,et al. IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT31 , 2008, The Journal of Immunology.
[32] Yong‐jun Liu,et al. Interleukin 25 promotes the initiation of proallergic type 2 responses , 2007, The Journal of experimental medicine.
[33] S. Ziegler,et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells , 2007, The Journal of experimental medicine.
[34] Linda Abetz,et al. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.
[35] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[36] H. D. Liggitt,et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice , 2005, Nature Immunology.
[37] M. Fortini,et al. Signalling: γ-Secretase-mediated proteolysis in cell-surface-receptor signalling , 2002, Nature Reviews Molecular Cell Biology.
[38] Kathleen M. Smith,et al. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.
[39] M. Leach,et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.
[40] T. Out,et al. Influx of Neutrophils into the Airway Lumen at 4 h after Segmental Allergen Challenge in Asthma , 1999, International Archives of Allergy and Immunology.
[41] S. Durham,et al. IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression , 1997, Immunology.